What's Behind the Recent Insider Selling at NewAmsterdam Pharma (NAMS)

Related Articles

What's Behind the Recent Insider Selling at AnaptysBio

5 months ago

What's Behind the Recent Insider Selling at Vicor

4 months ago

What's Behind the Recent Insider Selling at International Seaways

6 months ago

What's Behind the Recent Wave of Insider Selling at CoreWeave

6 months ago

Category

You may also like

Stock News•1 months ago

NeOnc Technologies- Talk Is Cheap, Insider Buying Isn't

NeOnc Technologies CEO Amir Heshmatpour bought 15,000 NTHI shares on August 14–17 at $3.79–$4.37, signaling insider confidence amid ongoing open-market purchases.

NTHI

Share

Stock News•1 months ago

What Three Encompass Health Insiders Selling Signals After a Rate Increase

An Encompass Health insider sold ~$1.1M of stock at $125.95/share, cutting direct holdings by 11%, after a recent rate increase. The sale may signal reduced insider conviction, though it remains a rou...

EHC

Share

Stock News•1 months ago

NewAmsterdam Pharma Company N.V. (NAMS) Analyst/Investor Day Transcript

NewAmsterdam Pharma (NAMS) hosted an Analyst/Investor Day, providing updates on its pipeline and strategy. The event may influence near-term sentiment as investors assess clinical and regulatory miles...

NAMS

Share